Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

ImmunoCellular Therapeutics (IMUC) Stock Price & Analysis

187 Followers

IMUC Stock Chart & Stats

$0.05$0.00(0.00%)
At close: 4:00 PM EST
$0.05$0.1$0.15$0.2Aug 11Aug 20Sep 8Sep 22Oct 5Oct 21Nov 2
Day’s Range
$0.05 - $0.05
52-Week Range
$0.02 - $0.27
Previous Close
$0.05
Volume
N/A
Average Volume (3M)
2,709
Market Cap
$6.59M
Enterprise Value
$32.30T
Total Cash (Recent Filing)
$613.24K
Total Debt (Recent Filing)
$3.47M
Price to Earnings (P/E)
―
Beta
-0.76
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

IMUC FAQ

What was ImmunoCellular Therapeutics’s price range in the past 12 months?
ImmunoCellular Therapeutics lowest stock price was $0.02 and its highest was $0.27 in the past 12 months.
What is ImmunoCellular Therapeutics’s market cap?
ImmunoCellular Therapeutics’s market cap is $6.59M.
When is ImmunoCellular Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ImmunoCellular Therapeutics’s earnings last quarter?
ImmunoCellular Therapeutics released its earnings results on Aug 13, 2018. The company reported -$0.1 earnings per share for the quarter.
Is ImmunoCellular Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ImmunoCellular Therapeutics pay dividends?
ImmunoCellular Therapeutics does not currently pay dividends.
What is ImmunoCellular Therapeutics’s EPS estimate?
ImmunoCellular Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImmunoCellular Therapeutics have?
ImmunoCellular Therapeutics has 126,502,860 shares outstanding.
What happened to ImmunoCellular Therapeutics’s price movement after its last earnings report?
ImmunoCellular Therapeutics reported an EPS of -$0.1 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of ImmunoCellular Therapeutics?
Currently, no hedge funds are holding shares in IMUC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology